Goldman Sachs Updates Its Estimates On Medtronic

Due to lower assumptions on ex-US ICD industry market growth, Goldman Sachs has updated its FY2011-2013 EPS estimates on Medtronic MDT to $3.38/$3.63/$3.95 from $3.39/$3.63/$3.96. It does not view these changes as material, and there is no change to the investment thesis, rating or price target. Goldman Sachs has a $45 PT and Buy rating on MDT MDT closed Monday at $39.54